Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Alginate oligosaccharide (G-block) fragment

EU orphan designation number: EU/3/07/475   
Active ingredient: Alginate oligosaccharide (G-block) fragment
Indication: Treatment of cystic fibrosis
Sponsor: AlgiPharma AS
Industriveien 33, 1337 Sandvika, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Orphan designation EMEA/OD/104/06 (2007)4337 of 14/09/2007
4/02/2009 Change of name and/or address of sponsor